An optimized long QT syndrome differentiating protocol: A new indication for wearable cardioverter-defibrillator vests

A wearable cardioverter-defibrillator vest as a diagnostic and therapeutic tool after COVID-19

“…Using a WCD as a bridge therapy can be an effective temporary solution in cases where the patient is at risk of SCD but is not yet a candidate for a permanent ICD implantation [3]. In this case, the WCD was a valuable diagnostic and therapeu-tic tool to prevent SCD [4]. Eventually, the arrhythmia resolved, and the patient decided not to have an ICD implanted, which, in hindsight, turned out to be the right decision, and the patient was not burdened with unnecessary therapy.…”

Wearable cardioverter-defibrillator in daily clinical practice: A single-centre experience

“…WEARIT-II and WEARIT-France are two big registries that show that WCD therapy is effective and safe in selected patients with a transient increased risk of SCD [5,6]. Apart from SCD protection, WCD provides also permanent telemetric monitoring which in several situations may allow for greater insight into patients' disease [7,8]. We aim to present a Polish single-center experience with WCD.…”